News
There are No Bad Emotions!
When we experience large emotions, our first instinct is to want to get rid of them, avoid them, or push...
Update from the TRANSMET trial: survival benefit seen for patients with unresectable colorectal liver metastases
August 2024 Patients living with colorectal liver metastases that cannot be removed by surgery experience poor long-term survival outcomes. The...
What is the impact of red and processed meat consumption on occurrence of chronic diseases and mortality?
August 2024 A recent study conducted in the United States showed that when unprocessed red meat and processed meat consumption...
The Most Common Question: Why Did I Get Cancer?
The most common question we receive in Support Services from folks who have been diagnosed with cancer is “why did...
Long-lasting response in a subset of locally advanced rectal cancer patients in response to dostarlimab immunotherapy
June 2024 Early clinical results have shown that locally advanced (stage III) mismatch repair deficient (dMMR) rectal cancers can respond...
Immunotherapy prior to surgery may improve outcomes for some patients with colorectal cancer
June 2024 A phase II study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting aimed to...
Get social
There are No Bad Emotions!
When we experience large emotions, our first instinct is to want to get rid of them, avoid them, or push...
Update from the TRANSMET trial: survival benefit seen for patients with unresectable colorectal liver metastases
August 2024 Patients living with colorectal liver metastases that cannot be removed by surgery experience poor long-term survival outcomes. The...
What is the impact of red and processed meat consumption on occurrence of chronic diseases and mortality?
August 2024 A recent study conducted in the United States showed that when unprocessed red meat and processed meat consumption...
The Most Common Question: Why Did I Get Cancer?
The most common question we receive in Support Services from folks who have been diagnosed with cancer is “why did...
Long-lasting response in a subset of locally advanced rectal cancer patients in response to dostarlimab immunotherapy
June 2024 Early clinical results have shown that locally advanced (stage III) mismatch repair deficient (dMMR) rectal cancers can respond...
Immunotherapy prior to surgery may improve outcomes for some patients with colorectal cancer
June 2024 A phase II study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting aimed to...
